← Back to All Stocks
Enlivex Therapeutics Ltd. (ENLV) Analysis
Generated on: 2025-06-22 13:59:12 UTC
All stock prices are delayed.
Use of this site does not constitute financial advice.
Analysis Values
Current Price
$1.04
Predicted Price
$1.25
Expected Return
16.46%
Confidence Score
0.83
RSI (14)
70.92 (sell)
MACD
0.01
Volume
139,300
Float Shares
20,949,067
Reddit Posts
0
News Items
1
SEC Filings
0
Data Points
249
ENLV
Enlivex Therapeutics Ltd.
16.46%
Price: $1.04
Confidence: 0.83
News
Last updated: 2025-06-22 13:59:12
Technical Analysis
RSI:
70.92 (sell)
MACD: 0.01
Risk Analysis
Volatility
69.17%
Max Drawdown
-50.24%
Beta
1.0
Risk Score
67.8
Social Sentiment
0
Social Sentiment Score (0-100)
Recent News
Enlivex enrols all patients in Phase II stage of knee osteoarthritis trial
Clinical Trials Arena - 2025-04-22 10:17
Enlivex anticipates releasing topline data from the Phase II stage, including full three-month endpoints, by this August.
Reddit Discussions
No recent Reddit discussions found.
Recent SEC Filings
No recent SEC filings found.
